Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patients-Reference-Cited by-同舟云学术

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patients

Published:1998-10 Issue:11 Volume:34 Page:1715-1720
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Sakata Y,Ohtsu A,Horikoshi N,Sugimachi K,Mitachi Y,Taguchi T

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Kelsen DP. Cancer of the Stomach, Cancer, Principles and Practice of Oncology, 4th edn. Philadelphia, J.B. Lippincott, 1993, 838–848.

2. The treatment of advanced gastric cancer;Wils;Semin Oncol,1996

3. Sakata Y, Suzuki H. Do we have a strategy for gastrointestinal cancers at present and in the future? Cancer Chemotherapy, 10. Tokyo, Japan, Excerpta Medica, 1995, 169–180.

4. Continuous 5-fluorouracil infusion in advanced gastric carcinoma;Moynihan;Am J Clin Oncol,1988

5. Re-evaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics;Spicer;Cancer Res,1988

Cited by 447 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel animal model of tegafur-induced hand-foot syndrome;Toxicology and Applied Pharmacology;2024-06

2. Impaired Consciousness Due to Hyperammonemia During S-1 Administration for Unresectable Pancreatic Cancer;Internal Medicine;2024

3. S-1 maintenance therapy in advanced gastric cancer without disease progression after first-line chemotherapy: A retrospective analysis;Science Progress;2023-10

4. Phase II Study of SOXIRI (S-1/Oxaliplatin/Irinotecan) Chemotherapy in Patients with Unresectable Pancreatic Ductal Adenocarcinoma: A Prospective Study (Preprint);2022-06-21

5. Association of renal function with the safety and efficacy of cisplatin plus S-1 therapy and docetaxel plus cisplatin plus S-1 therapy in patients with advanced gastric cancer: an exploratory analysis of JCOG1013;Japanese Journal of Clinical Oncology;2021-10-20